The Future of Oncology Biomarkers

Funding: INTERNATIONALISATION OF SMEs THROUGH INNOVATION  NETWORKS AND INNOVATION CENTRES (350.000 DKK). Ministry of Higher Education and Science.


Period: 2017


Description: A study tour to Israel for Danish SMEs, networks and research institutions comprising of a Danish-Israeli scientific symposium on the recent progress in the research and development of biomarkers within oncology, participation at the international Biomed 2017 conference and visit to a leading Israeli research institution or hospital specialising in oncology. The purpose of the project is the advancement of an innovation platform for exchange of scientific research data and the development of research and technology development collaborations with Israeli key players within oncology biomarkers.


Partners:

  • ICDK Tel Aviv
  • Bioneer
  • University of Copenhagen
  • BioJerusalem
  • Pharma Israel

 

Biopeople kontakt: Per Spindler


 

Boost4Health - The Life Sciences Hub of the North-West Europe (NWE) - To enhance innovation performance of enterprises throughout NWE regions

Funding: EU Interreg NWE (total budget 4,4 mEUR).


Period: 2016-2019


Description: The North-West Europe (NWE) life science sector is not exploiting its full potential due to the fragmented market and limited critical mass of its clusters. To grow sustainable new business, innovative NWE life science SMEs need to focus on international markets, but are held back by:

  • Lack of knowledge on internationalisation
  • Big differences in health care systems, cultures, re-imbursements etc.
  • Product validation under different regulationsVarious studies show that as a result European SMEs often remain small or sometimes prefer to move their business to the less complex US market to grow.

In Boost4Health, a partnership of 11 leading life science SME support organisations with strong business networks, will address this market failure by setting up a transnational support programme to help NWE SMEs grow internationally by bringing their life science innovations to European markets. The support programme consists of 3 outputs that will directly help SMEs overcome the above barriers: 1) International business growth strategy programme with coaching and matchmaking provided by support organisations, experts and peer companies, 2) Marketplace and €1,2M micro-funding programme to access international expertise (e.g. market insights, legal support), facilities (e.g. incubator, lab space), partners (e.g. business development support) and financing (e.g. innovative procurement, crowd-funding), and 3) European product validation network (clinical trial sites, hospitals, home care) for validating life science innovations with users abroadB4H uses innovative mechanisms where SMEs help other SMEs, building a strong transnational community that lasts beyond the project and positions NWE as a key life science hub.

B4H will help 300 SMEs increase their TRL levels through coaching, matchmaking and financial support thus bringing forward the introduction of new life sciences innovations to the international market.


Partners:

  • BOM Business Development & Foreign Investments B.V. (Netherlands, lead partner)
  • GM Business Support Ltd (UK)
  • Kent County Council (UK)
  • Ontwikkelingsmaatschappij Oost Nederland NV (Oost NV) (Netherlands)
  • Biocat, la Fundació BioRegió de Catalunya (Spain)
  • Université de Liège (Belgium)
  • ID2Santé, Innovation et Développement de la Santé en Bretagne (France)
  • BioRegio STERN Management GmbH (Germany)
  • Biopeople; University of Copenhagen (Denmark)
  • Eurasanté (France)

Project page (Ext. URL) 


Biopeople kontakt: Niels Westergaard and Randi Krogsgaard


 

Kvalificeret arbejdskraft til produktionsvirksomheder i Region Sjælland

Finansiering: Region Sjælland og in-kind medfinansiering fra virksomheder og partnere.


Total finansiering: Region Sjælland 2 mDKK, medfinansiering 2 mDKK.


Varighed: 2015-2017


Formål:
Projektet skal bidrage til, at andelen af nye medarbejdere med en videregående uddannelse fra en af regionens uddannelsesinstitutioner vil øges i Regionens produktionsvirksomheder, relateret til life science industrien.

Projektet skal udvikle, gennemføre og synliggøre praksis-rettede uddannelsesinitiativer og etablere nye samarbejder mellem regionens uddannelsesinstitutioner og virksomheder. Projektet vil endvidere bidrage til at sikre tilgængeligheden af medarbejdere med en videregående uddannelse.


Biopeoples rolle: Ansvarlig for projektledelse og kommunikation


Partnere:

RUC, University College Sjælland, Erhvervsakademi Sjælland, Novo Nordisk, Statoil.


Download faktaark.

www.kap-sjaelland.dk 


Biopeople kontakt: Niels Westergaard og Randi Krogsgaard 


 

Biomarkører som spirende vækstområde i Danmark

Finansiering: 5 mDKK heraf 2.8 mDKK fra Forsknings- og Innovationsstyrelsen


Varighed: 2016-2018


Beskrivelse: Europa skal fremover i høj grad leve af nye vækstområder, der opstår i krydsfeltet og i nye kombinationer mellem eksisterende teknologier og sektorer (på engelsk ”emergent industries”). Biomakører er et sådant vækstområde. 


Partnere: Bioneer, Brandbase (netværk for brands og branding, Syddansk Universitet), Infinit (Innovationsnetværk for IT, Alexandra Instituttet A/S, Aalborg Universitet). 


Ext URL: www.biomarkers.dk


Biopeople kontakt: Niels Westergaard


 

Food-IN-2-Health - Ingredients Innovation for Healthy Food

Bevillingsgiver: Forsknings- og Innovationsstyrelsen (BSR Innovation Express)


Samlet projektbevlling: 420 tDKK + privat medfinansiering


Bevillingsperiode: 2013-2016


Beskrivelse: Klynge-til-klynge internationaliserings-projekt rettet mod nye samarbejder.


Partnere: Teknologisk Institut, KU, DTU, VTT (Finland), foodRegio (Nordtyskland), inSPIRE, Nationale Ingrediens Center (NIC).


Ekstern henvisninger:

N/A


Biopeople kontakt: Per Spindler

European Patients’ Academy on Therapeutic Innovation

Niels Westergaard presenting at EUPATI meeting

Funding:  The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115334, resources of which are composed of financial contribution from the EU's 7th Framework Programme (FP7/2007-2013) and EFPIA companies.


Total amount 70 mDKK fra henholdsvis IMI og den europæiske forsknings-baserede industri (EFPIA virksomheder herunder Novo Nordisk A/S i Danmark) 


Timeline: 2012-2017


Description: Medicines research and development (R&D) is an increasingly complex process that remains a mystery for the majority of patients and the general public. Lifting the lid on the medical R&D process is the IMI-funded EUPATI project. EUPATI is a patient-led initiative that aims to develop the first European Patients’ Academy on Therapeutic Innovation, with training courses, educational material and an online public library that will empower patients to engage more effectively in the development and approval of new treatments and become true partners in pharmaceutical R&D.


Biopeople's role:
Biopeople is actively involved in the project and in the development of the educational material. Biopeople has established a patient-led national EUPATI platform in Denmark and works to increase the awareness of the project and its impacting importance.


Project Partners:

  • European Patients’ Forum (EPF) (projektleder)
  • European AIDS Treatment Group (EATG)
  • European Genetic Alliances Network (EGAN)
  • European Organisation for Rare Diseases (EURORDIS)
  • Amgen Belgium SA/NV
  • AstraZeneca AB
  • Bayer Pharma AG
  • Boehringer Ingelheim International GmbH
  • Chiesi Farmaceutici SpA
  • Eli Lilly and Company Ltd
  • Employers' Union of Innovative Pharmaceutical Companies INFARMA
  • F. Hoffmann-La Roche Ltd
  • Farmaindustria, Spain
  • GlaxoSmithKline R&D Ltd
  • Janssen Pharmaceutica NV
  • Laboratorios del Dr Esteve, SA
  • Merck KGaA
  • Novartis Pharma AG
  • Novo Nordisk A/S
  • Sanofi Aventis R&D
  • UCB Pharma SA
  • Verband forschender Artzneimittelhersteller eV
  • DIA Europe GmbH
  • European Forum for Good Clinical Practice
  • European Organisation for Research and Treatment of Cancer
  • Hibernia College
  • International Society for Pharmacoeconomics and Outcomes Research Inc., USA
  • Irish Platform for Patients' Organisations, Science and Industry
  • Nowgen / University of Manchester

Download fact sheet


Biopeople contact: Per Spindler and Niels Westergaard


 

Innovationskonsortiet Biofactory

Finansiering: Samlet budget er 31.5 mDKK heraf finansierer InnovationsFonden 13 mDKK.


Varighed: 2014-2018


Formål: BioFactory skal være med til at fremme brugen af naturlige værdistoffer fra planter til ingredienser i fødevarer, helsekost, naturmedicin og andre biologiske produkter. BioFactory skal styrke hele værdikæden for anvendelse af planteværdistoffer fra forskning over primærproduktion til forarbejdning og afsætning.


Beskrivelse: BioFactory er et innovationskonsortium, der skal undersøge, hvordan man ved hjælp af forædling, bioteknologi og nye produktionsmetoder kan designe planter, så de får et endnu højere indhold af værdistoffer. Det kan fx være naturlige farvestoffer til fødevarer eller indholdsstoffer til naturmedicin. Naturlighed er gået fra at være en verdensomspændende megatrend til en efterspørgselsfaktor, som industrien ikke kan komme udenom. En væsentlig del af forbrugerne fravælger i stigende grad produkter med kunstige tilsætningsstoffer og farver, hvis de kan få et naturligt alternativ. Og der er alternativer til mange af de klassiske tilsætningsstoffer, fx er det muligt fra planter som gulerødder og rødbeder at udvinde stoffer til farvning af fødevarer. Derudover er der en stor interesse for naturmedicin og helsekost som alternativ til medicin eller som kosttilskud.

Den store udfordring er imidlertid, at det i øjeblikket ikke er muligt at producere tilstrækkelige mængder af stofferne i Danmark. Årsagen er, at det ikke kan løbe rundt økonomisk, fordi udbytterne typisk er for lave. BioFactory tager udfordringen op og har som målsætning at øge indholdet af værdistoffer i planterne, bl.a. ved hjælp af avanceret bioteknologi.

Værdistoffer fra planter kan både bruges til at give farve, men de har også andre funktionelle egenskaber. Således vil BioFactory arbejde med rødkløver, der indeholder en type østrogener, der kan anvendes til lindring af gener ved kvinders overgangsalder. Derudover har konsortiet kig på planten rosenrod, der indeholder stofferne salidrosid og rosavin, der begge har vist sig effektive til at modvirke stress.

Innovationstemaer: Forædlingsmetoder, bioteknologiske metoder og Produktionssystemer.

Forskningstemaer: Fremme indholdet af planteværdistoffer, slægtshybridisering og krydsningsbarrierer, samt indhold af planteværdistoffer.


Partnere:

  • AgroTech A/S  (projektleder)
  • Chr. Hansen A/S
  • Knud Jepsen A/S
  • AdvanSeed ApS
  • Gartneriet Alfred Pedersen & Søn ApS
  • Herrens Mark ApS
  • Københavns Universitet – Det Natur- og Biovidenskabelige Fakultet, Institut for Plante- og Miljøvidenskab (KU-PLEN)
  • Syddansk Universitet, Det Tekniske Fakultet, Institut for Kemi-, Bio- og Miljøteknologi (SDU-KBM)
  • Biopeople, Denmark's Life Science Cluster
  • Landbrug og Fødevarer

Biopeople kontakt: Randi Krogsgaard


 

Niels Westergaard presenting at EUPATI meeting

Funding:  The project is receiving support from the Innovative Medicines Initiative Joint Undertaking, resources of which are composed of financial contribution from the EU's 7th Framework Programme and EFPIA companies.


Timeline: 2012-2017


Description: SafeSciMET has established a new and unique pan-European education and training network, providing master’s level courses in safety sciences for medicines. The training has focus on holistic, integrative and translational approaches.


Biopeople's role:
Couse Director. Biopeople / University of Copenhagen is involved in the training course concerning regulatory aspects of safety sciences.


Project Partners:

  • VU University Amsterdam
  • University of Konstanz
  • University of Surrey
  • EUFEPS
  • Uppsala University
  • University of Copenhagen
  • Universiteit Leiden
  • Universite de Lorraine
  • Martin-Luther-University
  • HalleKarolinska Institutet Stockholm
  • University of Vienna
  • Universite de Paris-Sud
  • MRC Centre for Drug Safety Science
  • Universidade de Lisboa
  • Charite University Medicine Berlin
  • Almirall
  • AstraZeneca Ltd
  • Bayer-Schering Pharma AG
  • Boehringer-Ingelheim Pharma
  • Eli-Lilly Ltd
  • GlaxoSmithKline Ltd
  • F. Hoffmann-La Roche
  • Lundbeck A/S
  • Merck KGaA
  • Novartis Pharma AG
  • Novo Nordisk A/S
  • Orion Pharma
  • Sanofi
  • UCB Pharma S.A.

External URL


 

Biopeople contact: Per Spindler


 

IN2LifeSciences - Boosting Innovation in Life Sciences

Funding: European Regional Development Funding (Interreg IVB)


Total amount 1.5 mEUR


Timeline: 2012-2015


Description: In2LifeSciences is the proof that huge amounts of confidence and small amounts of money make a great encouragement for future collaboration for both companies and project partners involved.

The project provided:

  • Easy-to-obtain financial incentives (worth €500, €4000 and €7000) that help SMEs begin collaborations with relevant experts, facilities or investors abroad
  • An Access Broker Network: single points of contact for each region, serving as easy-to-reach entry points to experts, facilities and funding abroad
  • International brokerage workshops and open innovation events to help SMEs find relevant organizations to collaborate with
  • An online directory of relevant facilities and experts in the eight IN2LifeSciences regions
  • Transnational elevator pitch events to help SMEs access foreign investors
  • Market access webinars 

Biopeople's role:  Regional Access Broker


Partnere:

  • Noord-Brabant Development Agency (BOM), The Netherlands (projektleder)
  • Oost N.V. & Health Valley, The Netherlands
  • Interface Enterprises-University of Liège, Belgium
  • CRITT Santé Bretagne, France
  • Atlanpole Biotherapies, France
  • BioRegio Stern, Germany
  • BiomeTI e.V., Germany

Link: IN2LifeSciences.eu


Download Fact Sheet


Biopeople contact: Niels Westergaard and Randi Krogsgaard


 

Biopeople
University of Copenhagen
Universitetsparken 2
DK-2100 Copenhagen
Denmark

Mail info@biopeople.ku.dk
Web www.biopeople.dk